Outlook Therapeutics (OTLK) EBITDA (2015 - 2026)
Outlook Therapeutics (OTLK) reported EBITDA of -$10.8 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with -$15.72 million a year earlier.
Powered by 
Analysis
Outlook Therapeutics (OTLK) EBITDA (2015 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Outlook Therapeutics' EBITDA came in at -$55.53 million; for FY2025 (ended Sep 30, 2025), it was -$66.94 million.
- By fiscal year, EBITDA came in at -$71.59 million in FY2024, -$52.94 million in FY2023, -$62.82 million in FY2022 and -$51.46 million in FY2021.
- The fiscal Q3 2026 figure ranks as the highest quarterly EBITDA since fiscal Q1 2024.
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at -$14 million (Q2 2026), -$13.45 million (Q1 2026) and -$17.28 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.34 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Outlook Therapeutics | 62.90 Mn | 27.15 Mn | -8,265.00 | -10.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10.78 Mn |
| Mar 31, 2026 | -13.97 Mn |
| Dec 31, 2025 | -13.42 Mn |
| Sep 30, 2025 | -17.26 Mn |
| Jun 30, 2025 | -15.69 Mn |
| Mar 31, 2025 | -12.33 Mn |
| Dec 31, 2024 | -21.55 Mn |
| Sep 30, 2024 | -22.82 Mn |
| Jun 30, 2024 | -19.53 Mn |
| Mar 31, 2024 | -18.91 Mn |
| Dec 31, 2023 | -10.29 Mn |
| Sep 30, 2023 | -12.44 Mn |
| Jun 30, 2023 | -18.00 Mn |
| Mar 31, 2023 | -6.83 Mn |
| Dec 31, 2022 | -15.67 Mn |
| Sep 30, 2022 | -13.93 Mn |
| Jun 30, 2022 | -16.97 Mn |
| Mar 31, 2022 | -18.84 Mn |
| Dec 31, 2021 | -13.08 Mn |
| Sep 30, 2021 | -13.38 Mn |
API Access
Outlook Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=OTLK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "OTLK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=OTLK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();